Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Awilco LNG | AWQ | 1. nov 2024 | 0.48 | -0.21 |
AXA | AXA | 1. nov 2024 | 34.33 | -0.03 |
Axa | AXAA | 1. nov 2024 | 34.00 | -0.58 |
Axactor | 2LJ | 1. nov 2024 | 0.31 | -4.06 |
Axalta Coating Systems Ltd. | 9AX | 1. nov 2024 | 34.60 | +0.58 |
Axcap Ventures | 1WJ0 | 1. nov 2024 | 0.09 | -29.50 |
Axcelis Technologies, Inc. | XXA1 | 1. nov 2024 | 79.14 | -2.51 |
Axfood | AXL1 | 1. nov 2024 | 20.11 | -0.10 |
aXichem A | A6X | 1. nov 2024 | 0.09 | -23.28 |
Axis Auto Finance Inc | X7D | 1. nov 2024 | 0.00 | 0.00 |
Axis Bank Ltd | UZC | 1. nov 2024 | 63.00 | 0.00 |
Axis Capital Holdings Limited | AXV | 1. nov 2024 | 72.50 | +1.40 |
Axogen, Inc. | LT3 | 1. nov 2024 | 12.80 | 0.00 |
Axolot Solutions Holding | 8Y1 | 1. nov 2024 | 0.02 | +19.05 |
Axon Enterprise, Inc. | TCS | 1. nov 2024 | 391.60 | -2.20 |
Axon Partners Group S.A. | XE1 | 1. nov 2024 | 14.30 | -3.38 |
Axos Financial, Inc. | BB4 | 1. nov 2024 | 62.00 | +1.64 |
Axsome Therapeutics, Inc. | 19X | 1. nov 2024 | 82.46 | +0.49 |
AXT Inc | AHV | 1. nov 2024 | 1.97 | -20.79 |
Axtel S.A.B. DE C.V. | 4GK | 1. nov 2024 | 0.03 | +4.62 |
Axway Software | 1XV | 1. nov 2024 | 27.40 | -0.36 |
Axxis Geo Solutions | S5B | 1. nov 2024 | 0.05 | +4.45 |
Aya Gold & Silver Inc | 0HE1 | 1. nov 2024 | 11.75 | +2.35 |
AYFIE GROUP NK 2 | 72H0 | 1. nov 2024 | 0.46 | +3.39 |
Ayr Wellness Inc. | 3KJB | 1. nov 2024 | 2.04 | +0.25 |
Ayurcann Holdings Corp | 3ZQ0 | 1. nov 2024 | 0.02 | +5.41 |
Azbil Corporation | YMK | 1. nov 2024 | 7.00 | -1.41 |
AZEK Company Inc | 4N1 | 1. nov 2024 | 40.00 | +0.50 |
Azimut Holding SpA | HDB | 1. nov 2024 | 22.67 | -0.74 |
Azkoyen S.A. | AKK | 1. nov 2024 | 6.26 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.